PrimeVigilance’s experts have been providing trainings on signal and benefit-risk management or pharmacoepidemiology for the DIA, regulatory authorities, and companies, as well as have been engaged in the teaching of advanced courses at the Basel Biocenter and other academic institutions.

This site uses cookies to personalise and customise your experience. No cookies collect personal or sensitive information. By clicking “I Accept", you consent to cookies in accordance with our cookie policy.